Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis: Results from an intermediate risk propensity-matched population of the Italian OBSERVANT study

被引:89
作者
D'Errigo, Paola [1 ]
Barbanti, Marco [2 ,3 ]
Ranucci, Marco [4 ,5 ]
Onorati, Francesco [6 ]
Covello, Remo Daniel [7 ]
Rosato, Stefano [1 ]
Tamburino, Corrado [2 ,3 ]
Santini, Francesco [6 ]
Santoro, Gennaro [8 ]
Seccareccia, Fulvia [1 ]
机构
[1] Ist Super Sanita, Natl Ctr Epidemiol Surveillance & Hlth Promot, I-00161 Rome, Italy
[2] Univ Catania, Div Cardiol, Ferrarotto Hosp, Catania, Italy
[3] ETNA Fdn, Catania, Italy
[4] IRCCS Policlin San Donato, Dept Cardiothorac & Vasc Anesthesia, Milan, Italy
[5] IRCCS Policlin San Donato, ICU, Milan, Italy
[6] Univ Verona, Sch Med, Div Cardiac Surg, I-37100 Verona, Italy
[7] IRCCS San Raffaele, Milan, Italy
[8] Careggi Hosp, Div Cardiol, Florence, Italy
关键词
Aortic stenosis; TAVI; SAVR; Intermediate risk; ONE-YEAR OUTCOMES; CLINICAL-OUTCOMES; EUROPEAN-SOCIETY; REGISTRY; COREVALVE; RETROGRADE; CARDIOLOGY; DISEASE; SURGERY; SYSTEM;
D O I
10.1016/j.ijcard.2012.05.028
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Few studies have yielded information on comparative effectiveness of transcatheter aortic valve implantation (TAVI) versus surgical aortic valve replacement (SAVR) procedures in a real-world setting. The aim of this analysis is to describe procedural and post-procedural outcomes in a TAVI/SAVR intermediate risk propensity-matched population. Methods: OBSERVANT is an observational prospective multicenter cohort study, enrolling AS patients undergoing SAVR or TAVI. Propensity score method was applied to analyze procedural and post-procedural outcomes. Pairs of patients with the same probability score were matched (caliper matching). Results: The unadjusted enrolled population (N=2108) comprises 1383 SAVR patients, 602 transarterial-TAVI patients and 123 transapical-TAVI patients. Matched population comprised a total of 266 patients (133 patients for each group). A relatively low risk population was selected (mean logistic EuroSCORE 9.4 +/- 10.4% vs 8.9 +/- 9.5%, SAVR vs TAVI; p=0.650). Thirty-day mortality was 3.8% for both SAVR and TAVI (p=1.000). The incidence of stroke (1.5% SAVR and 0.0% TAVI; p=0.156) and myocardial infarction (0.8% SAVR and 0.8% TAVI; p=1.000) was not statistically different between groups, whereas a higher requirement for blood transfusion was reported across the surgical cohort (49.6% vs 36.1%; p=0.026). A higher incidence of major vascular damage (5.3% vs. 0.0%; p=0.007) and pacemaker implantation(0.8% vs 12.0%; p=0.001) were reported in the TAVI group. Conclusions: Patients undergoing transcatheter and surgical treatment of severe aortic stenosis are still extremely distinct populations. In the relatively low-risk propensity-matched population analyzed, despite similar procedural and 30-day mortality, SAVR was associated with a higher risk for blood transfusion, whereas TAVI showed a significantly increased rate of vascular damage, permanent AV block and residual aortic valve regurgitation. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:1945 / 1952
页数:8
相关论文
共 32 条
[1]  
[Anonymous], G ITAL CARDIOL
[2]   Results of percutaneous and transapical transcatheter aortic valve implantation performed by a surgical team [J].
Bleiziffer, Sabine ;
Ruge, Hendrik ;
Mazzitelli, Domenico ;
Schreiber, Christian ;
Hutter, Andrea ;
Laborde, Jean-Claude ;
Bauernschmitt, Robert ;
Lange, Ruediger .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2009, 35 (04) :615-621
[3]   Aortic stenosis [J].
Carabello, Blase A. ;
Paulus, Walter J. .
LANCET, 2009, 373 (9667) :956-966
[4]  
D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO
[5]  
2-B
[6]   Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry [J].
Eltchaninoff, Helene ;
Prat, Alain ;
Gilard, Martine ;
Leguerrier, Alain ;
Blanchard, Didier ;
Fournial, Gerard ;
Iung, Bernard ;
Donzeau-Gouge, Patrick ;
Tribouilloy, Christophe ;
Debrux, Jean-Louis ;
Pavie, Alain ;
Gueret, Pascal .
EUROPEAN HEART JOURNAL, 2011, 32 (02) :191-197
[7]   Expanding the Eligibility for Transcatheter Aortic Valve Implantation The Trans-Subclavian Retrograde Approach Using the III Generation CoreValve Revalving System [J].
Fraccaro, Chiara ;
Napodano, Massimo ;
Tarantini, Giuseppe ;
Gasparetto, Valeria ;
Gerosa, Gino ;
Bianco, Roberto ;
Bonato, Raffaele ;
Pittarello, Demetrio ;
Isabella, Giambattista ;
Iliceto, Sabino ;
Ramondo, Angelo .
JACC-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (09) :828-833
[8]   Early and Late (One Year) Outcomes Following Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis (from the United States REVIVAL Trial) [J].
Kodali, Susheel K. ;
O'Neill, William W. ;
Moses, Jeffrey W. ;
Williams, Mathew ;
Smith, Craig R. ;
Tuzcu, Murat ;
Svensson, Lars G. ;
Kapadia, Samir ;
Hanzel, George ;
Kirtane, Ajay J. ;
Leon, Martin B. .
AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (07) :1058-1064
[9]   Standardized Endpoint Definitions for Transcatheter Aortic Valve Implantation Clinical Trials A Consensus Report From the Valve Academic Research Consortium [J].
Leon, Martin B. ;
Piazza, Nicolo ;
Nikolsky, Eugenia ;
Blackstone, Eugene H. ;
Cutlip, Donald E. ;
Kappetein, Arie Pieter ;
Krucoff, Mitchell W. ;
Mack, Michael ;
Mehran, Roxana ;
Miller, Craig ;
Morel, Marie-angele ;
Petersen, John ;
Popma, Jeffrey J. ;
Takkenberg, Johanna J. M. ;
Vahanian, Alec ;
van Es, Gerrit-Anne ;
Vranckx, Pascal ;
Webb, John G. ;
Windecker, Stephan ;
Serruys, Patrick W. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (03) :253-269
[10]   Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery [J].
Murphy, Gavin J. ;
Reeves, Barnaby C. ;
Rogers, Chris A. ;
Rizvi, Syed I. A. ;
Culliford, Lucy ;
Angelini, Gianni D. .
CIRCULATION, 2007, 116 (22) :2544-2552